What Causes High RBC Count: From Dehydration to Disease

A high red blood cell (RBC) count can stem from something as simple as not drinking enough water or from something as serious as a bone marrow cancer. The medical term for an elevated RBC count is erythrocytosis, and doctors split it into two broad categories: relative, where the number of red cells looks high only because the liquid part of blood has shrunk, and absolute, where the body is genuinely churning out more red cells than normal. That distinction matters because the causes, risks, and treatments differ sharply between the two.

The Dehydration Illusion

Dehydration is probably the most common reason a routine blood test comes back showing a high RBC count. When you lose fluid through sweating, vomiting, diarrhea, or simply not drinking enough, the watery plasma in your blood decreases while the red cells stay put. The result is a more concentrated blood sample that looks like it has too many red cells per unit of volume. Burns and heavy diuretic use can do the same thing. This is called relative erythrocytosis because no extra red cells were made; they just got packed into less fluid.¹

The tip-off is usually the clinical picture: the person is visibly dehydrated, their blood urea nitrogen may be elevated, and once they rehydrate, the RBC count falls right back to normal. No further workup is needed. The reason this matters is that a doctor who sees a high hematocrit on a lab report should first rule out this benign explanation before chasing rarer diseases.

How the Body Ramps Up Red Cell Production

When the cause is absolute erythrocytosis, the body has actually ramped up production of red blood cells. The master switch for this is erythropoietin (EPO), a hormone made mostly by the kidneys. When oxygen levels in the blood drop, kidney cells sense the change and release more EPO, which travels to the bone marrow and tells it to crank out red cells.² The oxygen-sensing proteins that trigger this cascade are called hypoxia-inducible factors, and they also boost iron absorption from the gut and adjust the bone marrow environment so new red cells mature faster.³

This pathway is remarkably efficient. It evolved to keep tissues oxygenated in all sorts of conditions, from blood loss to high altitude. But it can be tricked or hijacked by smoking, lung disease, hormone therapy, and even tumors, all of which push RBC counts higher than they need to be.

Living at High Altitude

People who live or work at high elevations breathe thinner air with less oxygen per breath. The body compensates by increasing ventilation, pumping more blood per heartbeat, and producing more red cells to carry oxygen more efficiently.⁴ A modest bump in RBC count is a healthy adaptation. Hemoglobin levels in highland residents often run well above what would be flagged as abnormal at sea level.

The problem arises when this adaptive response overshoots. In some high-altitude residents, erythrocytosis becomes excessive and leads to a condition called chronic mountain sickness, marked by headaches, fatigue, breathlessness, and dangerously thick blood.⁵ The line between helpful and harmful varies from person to person, which partly explains why some long-term highland residents feel fine while others develop symptoms.

Interestingly, not all high-altitude populations respond the same way. Tibetan populations, who have lived on the plateau for thousands of years, have evolved genetic changes that actually dampen the red-cell-boosting pathway, keeping their hemoglobin levels lower than those of more recent highland settlers.⁶ Their red cells appear to compensate in other ways, including higher oxygen affinity. This is a case where evolution found a smarter solution than simply making more red cells.

Smoking and Carbon Monoxide

Cigarette smoke delivers carbon monoxide into the lungs, and carbon monoxide binds hemoglobin far more tightly than oxygen does. The occupied hemoglobin molecules can no longer carry oxygen, so the body perceives a shortfall and starts making more red cells to compensate. Studies of heavy smokers show significantly higher RBC counts, hemoglobin, and hematocrit compared with nonsmokers.⁷

What is counterintuitive is the EPO side of the story. You might expect smokers’ EPO levels to be high, given that their tissues are chronically starved of oxygen. But research has found the opposite: serum EPO in smokers can drop by roughly 35% compared with nonsmokers, apparently because the elevated hemoglobin and RBC count create a negative feedback loop that suppresses further EPO release.⁷ The bone marrow is already busy; the kidneys get the signal that enough red cells are circulating and dial EPO back down. Quitting smoking usually reverses the elevated count over weeks to months.

Sleep Apnea and Chronic Lung Disease

Any condition that chronically lowers blood oxygen can push RBC production upward. Chronic obstructive pulmonary disease (COPD), cystic fibrosis, and cyanotic heart defects all qualify.⁸ The logic is the same as at altitude: less oxygen reaches the blood, the kidneys sense it, EPO goes up, and the marrow obliges.

Obstructive sleep apnea (OSA) is a slightly different story, and one where the popular understanding overshoots the evidence. Many clinicians assume OSA commonly causes a high RBC count because it produces repeated drops in oxygen during the night. And it is true that severe OSA can raise EPO levels: one study found a roughly 20% increase in EPO after just a few hours of untreated severe sleep apnea, with levels falling again once continuous positive airway pressure (CPAP) treatment was applied.⁹ However, research presented at major hematology meetings has found that true polycythemia caused solely by OSA is actually rare, and that clinicians who assume an elevated count is explained by a patient’s sleep apnea sometimes miss other diagnoses.¹⁰ In short, if your doctor finds a high RBC count and you have sleep apnea, the sleep apnea alone may not be the whole explanation.

Polycythemia Vera

Polycythemia vera (PV) is the condition that worries hematologists the most when they see a persistently elevated RBC count. It is a slow-growing blood cancer in which a mutation in the bone marrow causes red cells to multiply unchecked. In about 97% of PV cases, the culprit is a specific mutation in the JAK2 gene called V617F.¹¹ This mutation locks a growth signal in the “on” position, telling the bone marrow to produce red cells even without normal EPO stimulation. Lab studies confirm that marrow cells carrying the mutation are far more sensitive to EPO than normal cells, and cells with two copies of the mutation can grow independently of EPO altogether.¹²

PV differs from every other cause on this list in an important way: the EPO level is usually low or undetectable. In all the secondary causes discussed above, the body raises EPO in response to something it perceives as low oxygen. In PV, the marrow does not need the signal; it is already overproducing on its own, so the kidneys see plenty of oxygen being delivered and suppress EPO. That is why a low serum EPO level alongside a high RBC count is one of the strongest clues pointing toward PV rather than a secondary cause.

A Peculiar Symptom of PV

One of the stranger symptoms associated with polycythemia vera is aquagenic pruritus, an intense itching triggered by contact with warm water. People with PV sometimes describe it as the worst part of the disease: a burning, prickling itch that erupts within minutes of a shower and can last for an hour afterward. Skin biopsies taken after warm-water exposure show obvious mast cell degranulation in affected areas, suggesting that the itch is driven by mast cells releasing their contents into the skin.¹³ Aquagenic pruritus can precede a PV diagnosis by years, so anyone who develops mysterious itching after bathing and has not had a blood count checked should mention it to a doctor.

Testosterone and Anabolic Steroids

Testosterone therapy, whether prescribed for low testosterone or used illicitly for muscle building, reliably pushes RBC counts up. Over a 12-month period, testosterone administration in one study increased RBC count by about 9% and hemoglobin by about 8%.¹⁴ The mechanism works on two fronts: testosterone boosts EPO production in the kidneys and simultaneously suppresses hepcidin, a liver hormone that controls iron availability. When hepcidin drops, more iron becomes available for building new hemoglobin, and more iron gets incorporated into developing red cells.¹⁵

This is why hematocrit monitoring is standard practice for anyone on testosterone replacement therapy. If the hematocrit climbs above a certain threshold, doctors typically reduce the dose or temporarily stop treatment. Anabolic steroids used without medical supervision carry the same risk, often at higher doses and without monitoring, making dangerously thick blood a genuine hazard in that population.

Tumors That Make Their Own EPO

Certain tumors can hijack the EPO pathway by producing erythropoietin themselves, flooding the body with a growth signal the bone marrow cannot ignore. Kidney cancers are the most well-known culprits: roughly one to five percent of renal cell carcinomas are associated with polycythemia.¹⁶ Research using RNA analysis of these tumors has confirmed that the malignant cells themselves are producing EPO, rather than the surrounding normal kidney tissue. Hepatocellular carcinoma (liver cancer), uterine fibroids, and cerebellar hemangioblastomas have also been reported to secrete EPO in rare cases.

Tumor-driven erythrocytosis is uncommon enough that most people with a high RBC count will never need to worry about it. But it is one of the reasons a persistently elevated count in a person who does not smoke, lives at a normal altitude, and has no obvious lung disease warrants further investigation. Imaging of the kidneys and abdomen is sometimes part of that workup.

Inherited Genetic Causes

A small number of people are born with genetic variants that keep their red cell production permanently elevated. Familial erythrocytosis runs in families and can involve mutations in several different genes. Some families carry mutations in the EPO gene itself that cause overproduction of erythropoietin.¹⁷ Others have mutations in the oxygen-sensing machinery: loss-of-function changes in the PHD2 or VHL genes, or gain-of-function changes in the HIF-2α or EPO receptor genes, all of which trick the body into behaving as though oxygen is low when it is not.¹⁸

One notable example is Chuvash polycythemia, caused by a specific VHL mutation found at high frequency in the Chuvash population of Russia. People with this condition tend to have elevated RBC counts from childhood. Understanding these rare genetic forms has been scientifically valuable because they illuminate exactly how the oxygen-sensing pathway works in health and disease.

When a High RBC Count Becomes Dangerous

The main danger of persistently elevated red blood cells is that thicker blood can increase the risk of clots. A large community-based study found that people with hematocrit values above the 95th percentile had roughly 72% higher risk of venous blood clots compared with people in the middle range.¹⁹ Strokes and heart attacks can also occur when blood viscosity climbs high enough to slow flow through small vessels.

However, the relationship between hematocrit and clotting risk is not as straightforward as it looks. Research into different types of erythrocytosis has found that thrombosis does not accompany most forms of elevated RBC count, and that in some conditions like Chuvash polycythemia, the clotting risk appears to be independent of how high the hematocrit actually is.²⁰ There is even evidence that phlebotomy (drawing blood to lower the count) can paradoxically increase thrombotic risk in certain inherited erythrocytosis subtypes and may carry greater clotting risk than drug therapy in polycythemia vera. The take-home point is that a high RBC count is not automatically dangerous, and treatment decisions depend heavily on what is causing the elevation.

Blood Doping and Artificially Boosted RBC Counts

Endurance athletes have long known that more red cells means more oxygen delivery to working muscles, and some have tried to exploit this through blood doping. The two main methods are injecting synthetic EPO (recombinant human erythropoietin, or rhEPO) and transfusing stored red blood cells before competition. Controlled trials have shown that even small doses can improve endurance performance by roughly 4% to 6%, driven primarily by increased oxygen-carrying capacity and greater oxygen extraction by muscles.²¹

A 4% to 6% gain sounds modest in everyday terms, but in elite competition it is enormous, easily the difference between a podium finish and the middle of the pack. Anti-doping agencies test for synthetic EPO through blood and urine profiles, but detecting micro-dosing remains a challenge. From a health standpoint, blood doping carries the same viscosity risks described above: artificially thick blood can trigger strokes and cardiac events, and several sudden deaths in endurance sports during the 1980s and 1990s were widely attributed to EPO abuse before testing was implemented.

The biology of blood doping and the biology of high-altitude adaptation are, mechanistically, the same pathway being triggered by different stimuli. That overlap is why altitude training camps and “live high, train low” strategies are legal in sport: they exploit the body’s natural EPO response rather than injecting the hormone directly. Whether the ethical line between the two is as clean as the rules suggest is a debate that has never quite been settled.